Restless legs syndrome: Nonpharmacologic and pharmacologic treatments

John W. Winkelman; Richard P. Allen; Penny Tenzer; Wayne Hening

Restless legs syndrome: Nonpharmacologic and pharmacologic treatments

John W. Winkelman, Richard P. Allen, Penny Tenzer, Wayne Hening

Research output: Contribution to journal › Review article › peer-review

Abstract

Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.

Original language	English (US)
Pages (from-to)	13-16
Number of pages	4
Journal	Geriatrics
Volume	62
Issue number	10
State	Published - Oct 1 2007
Externally published	Yes

Keywords

Anticonvulsants
Dopamine agonists
Iron supplementation
Opioids
Restless legs syndrome
Sedatives
Sleep deprivation

ASJC Scopus subject areas

Geriatrics and Gerontology

Cite this

@article{48b6073be7e44e1bb3450ba795ffb811,

title = "Restless legs syndrome: Nonpharmacologic and pharmacologic treatments",

abstract = "Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.",

keywords = "Anticonvulsants, Dopamine agonists, Iron supplementation, Opioids, Restless legs syndrome, Sedatives, Sleep deprivation",

author = "Winkelman, {John W.} and Allen, {Richard P.} and Penny Tenzer and Wayne Hening",

year = "2007",

month = oct,

day = "1",

language = "English (US)",

volume = "62",

pages = "13--16",

journal = "Geriatrics",

issn = "0016-867X",

publisher = "Advanstar Communications",

number = "10",

}

TY - JOUR

T1 - Restless legs syndrome

T2 - Nonpharmacologic and pharmacologic treatments

AU - Winkelman, John W.

AU - Allen, Richard P.

AU - Tenzer, Penny

AU - Hening, Wayne

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.

AB - Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.

KW - Anticonvulsants

KW - Dopamine agonists

KW - Iron supplementation

KW - Opioids

KW - Restless legs syndrome

KW - Sedatives

KW - Sleep deprivation

UR - http://www.scopus.com/inward/record.url?scp=35349029765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35349029765&partnerID=8YFLogxK

M3 - Review article

C2 - 17922563

AN - SCOPUS:35349029765

SN - 0016-867X

VL - 62

SP - 13

EP - 16

JO - Geriatrics

JF - Geriatrics

IS - 10

ER -

Restless legs syndrome: Nonpharmacologic and pharmacologic treatments

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this